Breaking News

Sartorius Stedim Cellca Expands

Biopharma provider purchases property in Science Park III of Ulm

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Cellca, based near Ulm in southern Germany, purchased property of more than 6,000 square meters at Ulm’s Science Park III at Eselsberg to build a new laboratory and office complex. The new facility, which will approximately double the company’s space, is scheduled to be completed by the end of 2019. “Our new site’s proximity to universities and research institutes in Ulm’s Scientific Park offers an excellent environment to promote our growing business for which we are also se...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters